Abstract
The radiological detection of brain metastases (BMs) is essential for optimizing a patient’s treatment. This statement is even more valid when stereotactic radiosurgery, a noninvasive image guided treatment that can target BM as small as 1–2 mm, is delivered as part of that care. The timing of image acquisition after contrast administration can influence the diagnostic sensitivity of contrast enhanced magnetic resonance imaging (MRI) for BM. Investigate the effect of time delayed acquisition after administration of intravenous Gadavist® (Gadobutrol 1 mmol/ml) on the detection of BM. This is a prospective IRB approved study of 50 patients with BM who underwent post-contrast MRI sequences after injection of 0.1 mmol/kg Gadavist® as part of clinical care (time-t0), followed by axial T1 sequences after a 10 min (time-t1) and 20 min delay (time-t2). MRI studies were blindly compared by three neuroradiologists. Single measure intraclass correlation coefficients were very high (0.914, 0.904 and 0.905 for time-t0, time-t1 and time-t2 respectively), corresponding to a reliable inter-observer correlation. The delayed MRI at time-t2 delayed sequences showed a significant and consistently higher diagnostic sensitivity for BM by every participating neuroradiologist and for the entire cohort (p = 0.016, 0.035 and 0.034 respectively). A disproportionately high representation of BM detected on the delayed studies was located within posterior circulation territories (compared to predictions based on tissue volume and blood-flow volumes). Considering the safe and potentially high yield nature of delayed MRI sequences, it should supplement the standard MRI sequences in all patients in need of precise delineation of their intracranial disease.
Similar content being viewed by others
References
Soffietti R, Rudā R, Mutani R (2002) Management of brain metastases. J Neurol 249:1357–1369
Kushnirsky M, Nguyen V, Katz JS et al (2016) Time-delayed contrast-enhanced MRI improves detection of brain metastases and apparent treatment volumes. J Neurosurg 124(2):489–495
Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48–54
Patel KR, Prabhu RS, Kandula S et al (2014) Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone. J Neurooncol 120(3):657–663
Yamamoto M, Serizawa T, Shuto T et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387–395
Lu JJ, Brady LW (eds) (2011) Decision making in radiation oncology. Springer, Berlin
Tsao MN, Rades D, Wirth A et al (2012) International practice survey on the management of brain metastases: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control. Clin Oncol 24(6):e81–e92
Tsao MN, Rades D, Wirth A et al (2012) Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2(3):210–225
Grzesiakowska U, Tacikowska M (2002) An assessment of the effectiveness of magnetic resonance imaging in delayed sequences after administration of Gd-DTPA contrast in the detection of metastatic lesions in the brain. Med Sci Monit 8(1):MT21–MT24
Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044
Aoyama H, Tago M, Kato N et al (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68:1388–1395
Brown PD, Asher AL, Ballman KV (2015) et al NCCTG N0574 (Alliance): a phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases. ASCO Annu Meet J Clin Oncol 33(suppl 18):LBA4
Correa DD, DeAngelis LM, Shi W et al (2004) Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 62:548–555
Cohen-Inbar O, Melmer P, Lee CC et al (2015) Leukoencephalopathy in long term brain metastases survivors treated with radiosurgery. J Neurooncol 126(2):289–298
Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491
Do L, Pezner R, Radany E et al (2009) Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases. Int J Radiat Oncol Biol Phys 73:486–491
Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol 29:134–141
Soffietti R, Cornu P, Delattre JY et al (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 13(7):674–681
Essig M, Anzalone N, Combs SE et al (2012) MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice. Am J Neuroradiol 33(5):803–817
Chen W, Wang L, Zhu W et al (2012) Multicontrast single-slab 3D MRI to detect cerebral metastasis. Am J Roentgenol 198(1):27–32
Yuh WTC, Fisher DJ, Engelken JD et al (1991) MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 180:485–491
Yuh WTC, Engelken JD, Muhonen MG et al (1992) Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. Am J Neuroradiol 13:335–345
Jeon JY, Choi JW, Roh HG et al (2014) Effect of imaging time in the magnetic resonance detection of intracerebral metastases using single dose gadobutrol. Korean J Radiol 15(1):145–150
Essig M, Weber MA, von Tengg-Kobligk H et al (2006) Contrast-enhanced magnetic resonance imaging of central nervous system tumors: agents, mechanisms, and applications. Top Magn Reson Imaging 10(2):237–246
Zhang B, MacFadden D, Damyanovich AZ et al (2010) Development of a geometrically accurate imaging protocol at 3 T MRI for stereotactic radiosurgery treatment planning. Phys Med Biol 55(22):6601–6615
Healy ME, Hesselink JR, Press GA et al (1987) Increased detection of intracranial metastases with intravenous Gd-DTPA. Radiology 165:619–624
Niendorf HP, Laniado M, Semmler W et al (1987) Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors. Am J Neuroradiol 8:803–815
Russell EJ, Geremia GK, Johnson CE et al (1987) Multiple cerebral metastases: detectability with Gd-DTPA-enhanced MR imaging. Radiology 165:609–617
Yuh WT, Tali ET, Nguyen HD et al (1995) The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. Am J Neuroradiol 16(2):373–380
Uysal E, Erturk SM, Yildirim H et al (2007) Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions. Am J Roentgenol 188:697–702
Knopp MV, Runge VM, Essig M et al (2004) Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 230:55–64
Runge VM, Kirsch JE, Burke VJ et al (1992) High-dose gadoteridol in MR imaging of intracranial neoplasms. J Magn Reson Imaging 2:9–18
Yuh WTC, Fisher DJ, Nguyen HD et al (1992) The application of contrast agents in the evaluation of neoplasms of the central nervous system. Top Magn Reson Imaging 4(4):1–6
Haustein J, Laniado M, Niendorf H-P et al (1992) Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength. Am J Neuroradiol 13:1199–1206
Jacobs AH, Kracht LW, Gossmann A et al (2005) Imaging in neurooncology. NeuroRx 2(2):333–347
Suh CH, Kim HS, Choi YJ et al (2013) Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging. Am J Neuroradiol 34:2278–2286
Lewis T (2015) Human brain: facts, anatomy & mapping project. http://www.livescience.com/29365-human-brain.html. Accessed 10 2015
Swanson LW (1995) Mapping the human brain: past, present, and future. Trends Neurosci 18(11):471–474
Brain, brain information, facts, news, photos—National Geographic. http://science.nationalgeographic.com/science/health-and-human-body/human-body/brain-article/. Accessed 10 2015
Cohen-Inbar Or (2015) Focused neuroanatomy. Nova Publishers, New York
Oktar SO, Yücel C, Karaosmanoglu D et al (2006) Blood-flow volume quantification in internal carotid and vertebral arteries: comparison of 3 different ultrasound techniques with phase-contrast MR imaging. Am J Neuroradiol 27(2):363–369
Hallgren KA (2012) Computing inter-rater reliability for observational data: an overview and tutorial. Tutor Quant Methods Psychol 8(1):23–34
Martini N (1993) Operable lung cancer. CA Cancer J Clin 43:201–214
Russell DJ, Rubenstein LJ (eds) (1989) Pathology of tumours of the nervous system, 5th edn. Williams & Wilkins, Baltimore, pp 825–841
Sze G, Johnson C, Kawamura Y et al (1998) Comparison of single and triple-dose contrast material in the MR screening of brain metastases. Am J Neuroradiol 19(5):821–828
Quattrocchi CC, Errante Y, Gaudino C et al (2012) Spatial brain distribution of intra-axial metastatic lesions in breast and lung cancer patients. J Neurooncol 110(1):79–87
Hawighorst H, Schad LR, Gademann G et al (1995) A 3D T1-weighted gradient-echo sequence for routine use in 3D radiosurgical treatment planning of brain metastases: first clinical results. Eur Radiol 5:19–25
Wilkinson ID, Jellineck DA, Levy D et al (2006) Dexamethasone and enhancing solitary cerebral mass lesions: alterations in perfusion and blood-tumor barrier kinetics shown by magnetic resonance imaging. Neurosurgery 58(4):640–646
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no personal or institutional financial interest in drugs or materials in relation to this paper.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Cohen-Inbar, O., Xu, Z., Dodson, B. et al. Time-delayed contrast-enhanced MRI improves detection of brain metastases: a prospective validation of diagnostic yield. J Neurooncol 130, 485–494 (2016). https://doi.org/10.1007/s11060-016-2242-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-016-2242-6